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A B S T R A C T
Biosynthesis of benzylpenicillin in ﬁlamentous fungi (e.g. Penicillium chrysogenum - renamed as Penicillium ru-
bens- and Aspergillus nidulans) depends on the addition of CoA-activated forms of phenylacetic acid to iso-
penicillin N. Phenylacetic acid is also detoxiﬁed by means of the homogentisate pathway, which begins with the
hydroxylation of phenylacetic acid to 2-hydroxyphenylacetate in a reaction catalysed by the pahA-encoded
phenylacetate hydroxylase. This catabolic step has been tested in three diﬀerent penicillin-producing strains of
P. rubens (P. notatum, P. chrysogenum NRRL 1951 and P. chrysogenum Wisconsin 54–1255) in the presence of
sucrose and lactose as non-repressing carbon sources. P. chrysogenumWisconsin 54–1255 was able to accumulate
2-hydroxyphenylacetate at late culture times. Analysis of the P. rubens genome showed the presence of several
PahA homologs, but only Pc16g01770 was transcribed under penicillin production conditions. Gene knock-down
experiments indicated that the protein encoded by Pc16g01770 seems to have residual activity in phenylacetic
acid degradation, this catabolic activity having no eﬀect on benzylpenicillin biosynthesis. Proteome-wide ana-
lysis of the Wisconsin 54–1255 strain in response to phenylacetic acid revealed that this molecule has a positive
eﬀect on some proteins directly related to the benzylpenicillin biosynthetic pathway, the synthesis of amino acid
precursors and other important metabolic processes.
Signiﬁcance: The adaptive response of Penicillium rubens to benzylpenicillin production conditions remains to be
fully elucidated. This article provides important information about the molecular mechanisms interconnected
with phenylacetate (benzylpenicillin side chain precursor) utilization and penicillin biosynthesis, and will
contribute to the understanding of the complex physiology and adaptation mechanisms triggered by P. rubens (P.
chrysogenum Wisconsin 54–1255) under benzylpenicillin production conditions.
1. Introduction
Since Fleming's fortuitous discovery of penicillin ninety years ago,
constant eﬀorts have been made by the scientiﬁc community from in-
dustry and academia in order to improve penicillin titers. This has been
achieved mainly by industrial strain improvement programs, where
selected strains have been subjected during the last decades to several
rounds of radioactive and chemical mutagenesis, thus reaching product
titers and productivities three orders of magnitude higher than those
provided by the ancestor strains [1]. The fungal strain producing the
antimicrobial agent penicillin was initially identiﬁed by Fleming and
colleagues as Penicillium rubrum, which was later re-identiﬁed as Peni-
cillium notatum and ﬁnally placed in synonymy with Penicillium chry-
sogenum. However, this nomenclature has been recently reconsidered,
leading to the conclusion that Fleming's original strain, the full genome
sequenced strain P. chrysogenum Wisconsin 54–1255 and its ancestor
strain P. chrysogenum NRRL 1951 (wild-type), are in fact Penicillium
rubens [2]. Although all these strains are now classiﬁed as P. rubens, for
the sake of clarity the old names P. notatum, P. chrysogenum Wisconsin
54–1255 and NRRL-1951 are also used in this article, since hundreds of
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references using the old names have been published.
Much of the eﬀorts made by the scientiﬁc community have focused
on the biochemical and genetic characterization of the penicillin bio-
synthetic pathway [3] (Fig. 1), which is compartmentalized between
cytosol and peroxisomes (for reviews see [4, 5]). It starts with the non-
ribosomal condensation of L-α-aminoadipic acid, L-cysteine and L-va-
line by means of the nonribosomal peptide synthetase L-δ(α-aminoa-
dipyl)-L-cysteinyl-D-valine (ACV) synthetase (ACVS), which is a very
large multifunctional protein (MW 426 kDa). This protein is encoded by
the single structural 11-kbp pcbAB gene. Next, in a reaction catalysed by
the isopenicillin N (IPN) synthase or cyclase (encoded by the pcbC
gene), the ACV undergoes the oxidative ring closure of the tripeptide.
This leads to the formation of the bicyclic structure (penam nucleus) of
IPN in the cytosol. In the last step of the penicillin biosynthetic
pathway, the α-aminoadipyl side chain of IPN is replaced inside per-
oxisomes by a hydrophobic side chain activated as thioester with CoA.
In the case of benzylpenicillin, the side chain precursor is phenylacetic
acid, which is activated in the form of phenylacetyl CoA. Replacement
is catalysed by the penDE-encoded acyl-CoA: IPN acyltransferase (IAT),
which is synthesized as a 40-kDa precursor protein (proIAT) that un-
dergoes self-processing between residues Gly102 and Cys103. There-
fore, the active protein is a heterodimer comprising two subunits: α
(11 kDa, corresponding to the N-terminal fragment) and β (29 kDa,
corresponding to the C-terminal region). Activation of the side chain
precursor is achieved by means of aryl CoA-ligases. At least three aryl-
CoA ligases, encoded by the phl, phlB (aclA) and phlC genes, respec-
tively, have been reported to activate phenylacetic acid [6–9]. How-
ever, direct contribution to penicillin biosynthesis has only been de-
scribed in the case of the phenylacetyl CoA ligase encoded by the phl
gene [6].
Research has also been focused on the characterization of the
modiﬁcations introduced by industrial strain improvement programs.
Fig. 1. Metabolic routes of phenylacetic acid in P. rubens: penicillin biosynthetic pathway (upper chart) and homogentisate pathway (lower chart).
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Ampliﬁcation of the penicillin gene cluster is well documented in many
of the improved penicillin producers, which contain several copies of
this cluster (e.g. the AS-P-78 strain contains 5 or 6 copies) [10]. Mi-
crobodies (peroxisomes), the organelles where activation of the side
chain and its incorporation to the IPN molecule occur, are more
abundant in high-producer strains [11, 12]. Genome and transcriptome
analyses have also revealed that transcription of genes involved in the
biosynthesis of the penicillin amino acid precursors, as well as of those
genes encoding microbody proteins, was higher in the high-producer
strain DS17690 [12]. More recently, proteomics studies concluded that
the increase in penicillin production along the industrial strain im-
provement program was a consequence of complex metabolic re-
organizations, and suggested that energetic burden, redox metabolism
or the supply of precursors are crucial for the biosynthesis of this an-
tibiotic [13].
Besides this background knowledge, it is well known that the
homogentisate pathway for the catabolism of phenylacetic acid (the
side chain precursor in the biosynthesis of benzylpenicillin) to fumarate
and acetoacetate (Fig. 1) is diminished in Wisconsin 54–1255, and
presumably, in derived strains as well [14, 15]. Phenylacetic acid is a
weak acid that is toxic to cells depending on its concentration and
culture pH. This compound can be metabolized in P. rubens (P. chry-
sogenum) and Aspergillus nidulans (another ﬁlamentous fungus with the
ability to biosynthesize benzylpenicillin) through at least two routes;
incorporation to the benzylpenicillin molecule or catabolism via the
homogentisate pathway, which is also used to catabolize phenylalanine
and tyrosine [16–21]. The ﬁrst step of the phenylacetic acid catabolic
pathway is a 2-hydroxylation by a microsomal cytochrome P450
monooxygenase (phenylacetate hydroxylase) encoded in P. rubens by
the pahA gene (Pc21g14280) (Fig. 1). Little is known about the global
responses of this microorganism to the addition of the side-chain pre-
cursor, such as speciﬁc eﬀects on key enzymes of primary and sec-
ondary metabolism. Harris and co-workers [22] dissected the eﬀects of
phenylacetic acid on chemostat cultures using a microarray-based
analysis. These authors found that the homogentisate pathway was
strongly transcriptionally upregulated in those cultures supplemented
with the side chain precursor, as well as those genes involved in ni-
trogen and sulphur metabolism. This study provided an initial global
overview about the eﬀect of phenylacetic acid on fungal physiology,
although full exploitation of P. rubens (P. chrysogenum) requires the
integration of knowledge from other “omics”, such as proteomics.
In this work we provide information about the catabolism of phe-
nylacetic acid in three diﬀerent strains of P. rubens (P. notatum, P.
chrysogenum NRRL 1951 and P. chrysogenum Wisconsin 54–1255),
characterize the function of a putative phenylacetate hydroxylase
homolog in phenylacetate degradation and penicillin biosynthesis, and
analyse global modiﬁcations of the P. chrysogenum intracellular and
extracellular proteomes to the addition of the benzylpenicillin side
chain precursor.
2. Materials and methods
2.1. Strains and growth conditions
Three strains of P. rubens (Fleming's original isolate P. notatum; the
wild-type strain P. chrysogenum NRRL 1951; and the reference strain for
the genome and proteome projects, P. chrysogenum Wisconsin 54–1255
[12, 13, 23]), were used in this work. They were grown on solid Power
medium [24] for seven days at 28 °C. Conidia from one Petri dish were
collected and inoculated into a 500-mL ﬂask containing 100mL of de-
ﬁned inoculation medium (DIM) with 40 g/L glucose [24]. After 24 h of
incubation at 25 °C and at 250 rpm, a 10% of inoculum was added to a
500-mL ﬂask containing 100mL of deﬁned production medium
(MDFP), which was prepared by adding 1 g/L potassium phenylacetate,
30 g/L lactose and 10 g/L sucrose to the DIM medium without glucose,
and incubated under the same conditions for diﬀerent times.
For proteomics experiments, P. rubens (P. chrysogenum Wisconsin
54–1255) was grown as indicated above in deﬁned medium with 1 g/L
potassium phenylacetate. Control cultures lacked the side-chain pre-
cursor potassium phenylacetate. Cultures were incubated at 25 °C and
250 rpm and samples (mycelia and culture medium) were collected
after 60 h for intracellular and extracellular proteome analysis.
For expression analysis experiments, conidia were inoculated in
complex inoculum medium CIM [25] without phenylacetate. After in-
cubation at 25 °C for 20 h in an orbital shaker (250 rpm), aliquots (5%)
were inoculated in CP complex penicillin production medium [25] with
4 g/L potassium phenylacetate and incubated under the same condi-
tions for 48 h and 60 h.
For transformation experiments, conidia were inoculated into MPPY
medium (40 g/L glucose, 3 g/L NaNO3, 2 g/L yeast extract, 0.5 g/L KCl,
0.5 g/L MgSO4·7H2O, 0.01 g/L FeSO4·7H2O, pH=6.0) and grown for
24 h at 25 °C and 250 rpm.
2.2. Plasmid constructions for gene silencing
Plasmid pJL43-RNAi [26], which confers phleomycin resistance,
was previously digested with NcoI and used as backbone structure for
the constructions aimed to generate knock-down transformants in the
Pc16g01770 gene. Oligonucleotides 1770F (5′-GATCCCATGGCCATGA
TCCAGC-3′) and 1770R (5′-GATAGCCATGGCCGCCCGATC-3′), which
were designed to bear NcoI restriction sites (in italics), were used to
amplify a 473-bp exon fragment from Pc16g01770. The amplicon was
digested with NcoI and cloned into pJL43-RNAi, thus yielding plasmid
pJL43-RNAi-1770.
2.3. Transformation of P. rubens (P. chrysogenum Wisconsin 54–1255)
protoplasts, extraction of genomic DNA and Southern blotting
Protoplasts were obtained and transformed as previously described
[27]. Then, transformed protoplasts were grown in Czapek minimal
medium (30 g/L sucrose, 2 g/L NaNO3, 0.5 gLl K2HPO4, 0.5 g/L
MgSO4.7H2O, 0.01 g/L FeSO4) and further selected in Czapek minimal
medium containing 30 μg/mL phleomycin.
DNA isolation and Southern blotting hybridization were carried out
as previously described [28].
2.4. RNA extraction and semiquantitative RT-PCR assays
Cultures of P. rubens (P. chrysogenum Wisconsin 54–1255) were
grown in complex medium as indicated above during 48 h and 60 h.
Total RNA was extracted using “RNeasy Mini Kit” columns (Qiagen),
following the manufacturer's instructions. Total RNA was treated with
“RQ1 RNase-Free DNase” (Promega Corporation) and quantiﬁed using
a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientiﬁc).
RT-PCR was conducted with 200 ng of total RNA using the
“SuperScript One-Step RT-PCR with Platinum Taq” system (Invitrogen
Corporation) and applying 40 ampliﬁcation cycles as recommended by
the manufacturer. For the ampliﬁcation of a 473-bp fragment from
Pc16g01770, primers 1770F and 1770R (see above) were used. For the
ampliﬁcation of a 432-bp fragment from Pc22g02230, primers 2230F (
5′-GGATGCTAAGGCCTATGAAGG-3′) and 2230R (5′-GAAGATCCAATG
GTAAAGCCCTG-3′) were used. For the ampliﬁcation of a 457-bp frag-
ment from the actA-encoding β-actin gene, primers actAF (5′-CTGGCC
GTGATCTGACCGACTAC-3′) and actAR (5′-GGGGGAGCGATGATCTTG
ACCT-3′) were used. The absence of contaminating DNA in the RNA
samples was conﬁrmed by PCR.
For some experiments, densitometry analyses using the “Gel-Pro
Analyser” software (Media Cybernetics) were performed in order to
quantify the signals provided by the RT-PCR assays. The transcript le-
vels were normalized by comparing the intensity of each mRNA signal
to the β-actin mRNA signal. Expression levels were considered sig-
niﬁcantly diﬀerent according to the standard deviation and when the p-
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value provided by the Student's t-test was p < 0.01.
2.5. HPLC analysis
Extraction, analysis and quantitation of benzylpenicillin were car-
ried out by HPLC using an Agilent 1100 HPLC system with an analytical
4.6× 250mm (5 μm) RPC18 Lichrospher® 100 column as previously
described [29].
Phenylacetate and 2-hydroxyphenylacetate were extracted, ana-
lysed and quantiﬁed as follows. Culture supernatants (0.8 mL) were
mixed with cold HPLC-grade methanol (1:1 ratio) and left overnight at
4 °C for protein precipitation. Then, samples were centrifuged at
13,000 rpm for 10min at 4 °C and analysed by HPLC, which was carried
out using an Agilent 1100 HPLC system with an analytical
4.6× 150mm (3 μm) Mediterranea Sea18 Teknokroma® column with a
ﬂow rate of 1mL/min. Detector wavelength was set to 217 nm (for
potassium phenylacetate) or 270 nm (for 2-hydroxyphenylacetate).
Samples (10 μL) were injected in the HPLC using 1% triﬂuoroacetic acid
as solvent A and acetonitrile as solvent B. The elution gradient was as
follows: 10%B→ 55%B linear over 15min, 55%B→ 100%B linear over
1min, isocratic elution for 4min, 100%B→ 10%B for 0.5 min, isocratic
elution for 5.5 min. Under these conditions, the retention time for po-
tassium phenylacetate was 11.05 ± 0.15min, whereas for 2-hydro-
xyphenylacetate, the retention time was 8.45 ± 0.15min. The detec-
tion limit was 15 μg/mL.
2.6. Protein extraction
Proteins from either the mycelia (intracellular) or the culture su-
pernatants (extracellular) were obtained as previously described [13,
23]. The ﬁnal pellet was solubilized in sample buﬀer: 8M urea, 2% (w/
v) CHAPS, 0.5% (v/v) IPG Buﬀer (GE Healthcare), 20mM DTT, 0.002%
bromophenol blue. The insoluble fraction was discarded by cen-
trifugation at 16,000 x g for 5min. The supernatant was collected and
protein concentration was determined according to the Bradford
method, which showed a high reproducibility for this protein extraction
protocol.
2.7. 2-DE gel electrophoresis
A solution containing 350 μg of soluble intracellular proteins or
450 μg of soluble extracellular proteins in the sample buﬀer (see
above), was loaded onto 18-cm IPG strips (GE Healthcare), with non-
linear pH 3–10 gradient (for intracellular proteins) or non-linear pH 4–7
gradient (for extracellular proteins). Focusing of proteins and equili-
bration of the focused IPG strips were achieved as previously described,
as well as the second dimension, which was run by SDS-PAGE in 12.5%
polyacrylamide in an Ettan Dalt Six apparatus (GE Healthcare) [13, 23].
Gels were dyed with Colloidal Coomassie (CC) following the “Blue
Silver” staining method [30], which provides high reproducibility, as
indicated before [13, 23].
2.8. Analysis of diﬀerential protein expression
Scanned 2D gels were analysed using an ImageScanner II (GE
Healthcare) calibrated with a grayscale marker (Eastman Kodak Co.).
Labscan 5.00 (v1.0.8) software (GE Healthcare) and the
ImageMasterTM 2D Platinum v5.0 software (GE Healthcare) were used
for image acquisition and analysis as previously described [13, 23].
Three biological replicates were used for each condition. After auto-
mated spot detection, spots were checked manually to eliminate any
possible artefacts, such as streaks or background noise. Spot normal-
ization, as an internal calibration to make the data independent from
experimental variations among gels, was made using relative volumes
(volume of each spot divided by the total volume of all the spots in the
gel) to quantify and compare the gel spots. Diﬀerentially expressed
proteins between two strains were considered when the ratio of the
relative volume average for one speciﬁc spot (present in the three
biological replicates) was higher than 1.5 or lower than−1.5 and the p-
value was<0.05.
2.9. Protein identiﬁcation by MALDI-TOF MS and MS/MS
The spots of interest were manually excised from Colloidal
Coomassie-stained gels by biopsy punches, placed in an Eppendorf tube,
and washed twice with ddH2O. The proteins were digested following
the method of Havlis and co-workers [31] and processed for further
analysis as indicated before [13, 23]. The samples were analysed with a
4800 Proteomics Analyser MALDI-TOF/TOF mass spectrometer (Ap-
plied Biosystems). A 4700 proteomics analyser calibration mixture (Cal
Mix 5; Applied Biosystems) was used as external calibration. All MS
spectra were internally calibrated using peptides from the trypsin di-
gestion. The peptide mass ﬁngerprints results, with a signal to noise (S/
N) ratio> 20, were collected and represented as a list of monoisotopic
molecular weights using the 4000 Series Explorer v3.5.3 software
(Applied Biosystems). Well known contaminant ions (trypsin- and
keratin-derived peptides) were excluded for later MS/MS analysis.
Hence, the six most intensive precursors from each MS spectra with a S/
N>20 were selected for MS/MS analyses with CID (atmospheric gas
was used) in 2-kV ion reﬂector mode and precursor mass windows
of± 7Da. Default calibration was optimized for the MS/MS spectra.
Mascot Generic Files combining MS and MS/MS spectra were au-
tomatically created for protein identiﬁcation by means of a non-re-
dundant protein database using a local license of Mascot v 2.2 from
Matrix Science through the Protein Global Server (GPS) v 3.6 (Applied
Biosystems). The search parameters for peptide mass ﬁngerprints and
tandem MS spectra obtained were set as follows: (i) Uniprot
Ascomycota (date 2017.07.03; 6,766,808 sequences, 3,023,177,811
residues); (ii) ﬁxed and variable modiﬁcations were considered (Cys as
S carbamidomethyl derivative and Met as oxidized methionine); (iii)
one missed cleavage site was allowed; (iv) precursor tolerance was
100 ppm and MS/MS fragment tolerance was 0.3 Da; (v) peptide
charge: 1+; and (vi) the algorithm was set to use trypsin as the enzyme.
Protein candidates produced by this combined peptide mass ﬁnger-
printing (PMF)/tandem MS search were considered valid when the
global Mascot score was>83 with a signiﬁcance level of p < 0.05.
Additional criteria for conﬁdent identiﬁcation were that the protein
match should have at least 15% sequence coverage; for lower cov-
erages, only those proteins with at least two peptides identiﬁed were
considered valid.
3. Results
3.1. Catabolism of phenylacetic acid in three diﬀerent P. rubens strains
The behaviour of three diﬀerent penicillin-producing strains of P.
rubens (P. notatum, P. chrysogenum NRRL 1951 and P. chrysogenum
Wisconsin 54–1255) was tested in the presence of phenylacetic acid.
For this purpose, they were grown for 72 h in DP medium containing
1 g/L potassium phenylacetate (7 mM). All strains were able to grow in
the presence of potassium phenylacetate and showed a similar growth
pattern and biomass values with no signiﬁcant diﬀerences along the
culture time (Fig. 2A). Antibiotic production was analysed in the three
strains. As expected, P. chrysogenum Wisconsin 54–1255 produced the
highest benzylpenicillin titers (3,6 ± 1,2mg/g dry weight at 72 h),
which were 300-fold and 2000-fold higher than those provided by P.
chrysogenum NRRL 1951 and P. notatum, respectively (data not shown).
Phenylacetate consumption was similar in the three strains until 24 h.
After this time point, P. chrysogenum Wisconsin 54–1255 showed a
lower consumption rate than the wild-type parental strain P. chryso-
genum NRRL 1951 and P. notatum, which were the only strains able to
fully deplete the side chain precursor after 72 h of growth (Fig. 2B).
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This suggests that late steps in the catabolism of phenylacetic acid
might be limiting in this strain. As a control, a parallel abiotic experi-
ment was run with DP medium supplemented with 1 g/L potassium
phenylacetate (7 mM) and subjected to similar conditions. Phenylace-
tate levels remained constant along the culture time, thus excluding a
phenomenon of non-enzymatic degradation of this compound in the
absence of P. rubens (data not shown). To test the phenylacetate cata-
bolic activity of the three P. rubens strains, secretion of 2-hydro-
xyphenylacetate was assessed (Fig. 2C). Similar amounts of this meta-
bolite were found in the culture media of these strains at early time
points. P. notatum produced higher amounts of 2-hydroxyphenylacetate
at 48 h, and a gradual decrease in the amount of this compound was
observed from this time-point. P. chrysogenum NRRL 1951 showed a
slightly diﬀerent pattern, with a full depletion of this metabolite at 72 h.
Interestingly, in P. chrysogenum Wisconsin 54–1255, 2-hydro-
xyphenylacetate levels in the culture medium increased from 36 h of
growth until the end of the culture time (Fig. 2C).
3.2. Characterization of phenylacetate hydroxylase homologs in P. rubens
(P. chrysogenum Wisconsin 54–1255)
With the aim of shedding light into the degradation of phenylacetic
acid by the improved strain P. chrysogenum Wisconsin 54–1255, a
search for pahA-encoded phenylacetate hydroxylase (Pc21g14280)
Fig. 2. Catabolism of phenylacetic acid in three strains of P rubens (P. notatum, P chrysogenum NRRL 1951 and P. chrysogenum Wis 54–1255). A) Dry weight (mg/mL)
obtained from samples taken at diﬀerent time points. B) Consumption of potassium phenylacetate (μg/mL) along the culture time. C) Secretion of 2-hydro-
xyphenylacetate (2-OH phenylacetate) (μg/mL) along the culture time. Data correspond to three biological replicates performed in triplicate.
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homologs was carried out in the P. rubens (P. chryosogenum Wisconsin
54–1255) genome [12]. Three proteins were found with>50% simi-
larity with the pahA-encoded protein: Pc22g02230 (65% similarity,
46% identity), Pc16g01770 (62% similarity, 44% identity) and
Pc21g22560 (60% similarity, 42% identity). According to the sequence,
all proteins belonged to the Cytochrome P450 superfamily. In addition,
Pc21g22560 also contained GAL4-like (Zn2Cys6 binuclear cluster DNA-
binding) and fungal transcription factor regulatory middle homology
region domains, which suggested a diﬀerent role from phenylacetate
catabolism.
Therefore, we focused our research on Pc22g02230 and
Pc16g01770. Expression of these genes was analysed in cultures of P.
rubens (P. chrysogenum Wisconsin 54–1255), which was grown for 48 h
and 60 h in complex medium in the presence of 4 g/L potassium phe-
nylacetate. RT-PCR experiments (Fig. 3) showed that Pc16g01770 was
expressed along the culture time, unlike Pc22g02230, whose tran-
scription was not detected even after 50 ampliﬁcation cycles.
According to expression data, Pc22g02230 was discarded for further
analysis and the role of Pc16g01770 in phenylacetate degradation was
assessed by means of gene silencing experiments. For this purpose, P.
rubens (P. chrysogenum Wisconsin 54–1255) was transformed with
plasmid pJL43-RNAi-1770. Integration of the silencing cassette in dif-
ferent transformants was conﬁrmed by Southern blotting (Fig. 4A) after
the digestion of genomic DNA with SphI and HindIII, and hybridisation
to the DIG-labelled exon fragment (the same DNA fragment that was
included in the silencing cassette). All transformants and the parental
strain showed the 9.4-kbp hybridisation band containing the internal
Pc16g01770 gene. In addition, transformants 1, 5, 15, 38, 52 and 55
showed the 1.8-kbp band that included the silencing cassette. At-
tenuation of expression in these transformants was conﬁrmed by RT-
PCR (Fig. 4B). All transformants, except 52 and 55, showed signiﬁcant
(p < 0.05) reduced expression (ranging from 42% in transformant 15
to 17% in transformant 38) of the Pc16g01770 gene, and were phe-
notypically characterized.
Cultures of P. chrysogenum Wisconsin 54–1255 and knock-down
transformants 1, 5, 15 and 38 were conducted in deﬁned medium in the
presence of 1 g/L potassium phenylacetate. Samples were collected at
24 h, 48 h and 72 h and the presence of non-consumed phenylacetic
acid, 2-hydroxyphenylacetic acid and benzylpenicillin in the culture
supernatants was analysed by HPLC. Transformants 1, 5 and 15 showed
a slight (up to 20%) signiﬁcant (p < 0.05) increase in the phenylacetic
acid levels at 72 h regarding the values provided by the parental
Wisconsin 54–1255 strain (Fig. 5A). Also, the presence of 2-hydro-
xyphenylacetic acid was assessed in those transformants. In general,
they showed signiﬁcant (p < 0.05) slightly reduced levels (up to 25%)
of this compound at 48 h and 72 h (transformant 5 did not provide a
signiﬁcant decrease at 72 h), in comparison with the values provided by
the parental strain (Fig. 5B). This behaviour may be due to a reduced
degradation of the benzylpenicillin side chain precursor in the knock-
down transformants. Benzylpenicillin speciﬁc production remained si-
milar between transformants and the parental Wisconsin 54–1255
strains (Fig. 5C). These results suggest that Pc16g01770 may have a
residual activity in phenylacetic acid degradation in the Wisconsin
54–1255 strain, this catabolic activity having no eﬀect on benzylpeni-
cillin biosynthesis (see Discussion).
3.3. Eﬀect of phenylacetic acid on the intracellular and extracellular
proteomes of P. rubens (P. chrysogenum Wisconsin 54–1255)
In order to get more insight into the metabolic processes modiﬁed
by the presence of the benzylpenicillin side chain precursor, a pro-
teome-wide analysis was carried out in P. rubens (P. chrysogenum
Wisconsin 54–1255).
For this purpose, cultures were conducted with this fungal strain in
the presence and absence of 1 g/L phenylacetic acid. Samples included
both mycelia (for intracellular proteome analysis) and culture super-
natants (for extracellular proteome analysis) and were taken at 60 h of
growth. Protein fractions were analysed by 2-DE and tandem MS
spectrometry.
3.3.1. Intracellular proteome
The 2-DE gels with the intracellular protein fractions obtained from
both conditions were compared to each other (Fig. 6). A total of 22
spots (D1-D22 including 23 proteins) resulted overrepresented, whereas
53 spots (C1-C53 including 56 proteins) were underrepresented after
phenylacetic acid addition (Supplementary Tables S1 and S2). Func-
tions were inferred for these proteins (Tables 1 and 2) and the main
ﬁndings are summarized below.
Only one protein from the homogentisate pathway was found
overrepresented after the addition of phenylacetic acid (Table 1). Spot
D6 (4.5-fold overrepresented) contains the fumaryl acetoacetase
(Pc12g09030), which is involved in the last step of the catabolic
pathway of phenylacetic acid (see Discussion).
Interestingly, several proteins related to penicillin biosynthesis were
also found overrepresented after the addition of the benzylpenicillin
side chain precursor. The ﬁrst one is IAT (Pc21g21370), one of the
penicillin biosynthetic enzymes, which is included in spot D11 (5.8-fold
overrepresented). Other important proteins are present in Spot D4 (2.4-
fold overrepresented in the presence of phenylacetic acid and including
a hypothetical cystathionine beta synthase) Spot D23 (only detected
with phenylacetic acid and including a probable ketol-acid re-
ductoisomerase ilv-2) and Spot D22 (only detected after supplementa-
tion with phenylacetic acid and containing a probable thioredoxin
peroxidase (Pc22g04430)). Another interesting protein that resulted
overrepresented after phenylacetic acid addition is S-adenosylmethio-
nine synthase, which is included in spot D14 (2.9-fold overrepresented)
(See Discussion).
Several proteins that are underrepresented due to the presence of
phenylacetic acid (Table 2) belong to the glycolysis and tricarboxylic
acid cycle. Examples are provided by spots C7 (Pc18g01220, probable
fructose-bisphosphate aldolase), C12 (Pc18g06000, probable pyruvate
kinase), C27 and C28 (both including Pc20g01610, a probable mi-
tochondrial malate dehydrogenase), C40 (Pc22g02000, a probable
mitochondrial aconitate hydratase), and C45 and C46 (both including
Pc12g06870, a probable alpha subunit of succinyl coenzyme A syn-
thase). In addition, three spots related to the metabolism of acetyl-CoA
were also found underrepresented under these conditions: spot C9
(Pc21g20480, probable ATC citrate lyase), spot C11 (Pc12g03130, a
probable acetyl-CoA hydrolase) and spot C44 (Pc22g11710, probable
alpha subunit E1 of the pyruvate dehydrogenase complex). Related to
this ﬁnding is the fact that spot C2, which includes a probable N-
Fig. 3. Expression of putative pahA homologs in P. rubens (P. chrysogenum Wis
54–1255). Ethidium bromide-stained agarose gel showing the RT-PCR band
(473-bp) of Pc16g01770 that has been ampliﬁed from RNA samples taken at
48 h and 60 h. The absence of contaminating DNA in the RNA samples was
conﬁrmed by PCR (C-). Note the absence of RT-PCR bands for Pc22g02230
when RNA is used and the ampliﬁcation of a 432-bp PCR band from this gene
when genomic DNA is used as template (gDNA). Ampliﬁcation of RT-PCR
fragments (457 bp) from the actA-encoding β-actin gene was used as a reference
of transcription.
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acetylglucosamine-6-phosphate deacetylase (Pc22g10010), is 5.28-fold
underrepresented in the presence of phenylacetic acid. This enzyme
deacetylates amino sugars to yield glucosamine-6-phosphate and
acetate.
Another interesting group of proteins that resulted under-
represented after the addition of the benzylpenicillin side chain pre-
cursor were related to protein folding, modiﬁcation or degradation.
This is the case of spots C5 (Pc22g11240, probable heat shock protein
70 hsp70), C8 (Pc22g19990, probable endonuclease SceI 75 kDa sub-
unit Ens1 with putative hsp70 activity), C21 and C41 (both including
Pc22g10220, a probable dnaK-type molecular chaperone), C29
(Pc21g16970, vacuolar serine proteinase AAG44693 or allergen Pen n
18), C33 (probable proteasome component PRE6), C36 (Pc22g13950,
probable vacuolar aminopeptidase Ysci) and C49 (Pc20g09400, prob-
able dipeptidyl-peptidase V).
A subset of proteins related to oxidative stress response was also
underrepresented in the presence of phenylacetic acid. Examples are
provided by spots C3 (Pc12g14620, probable ﬂavohemoglobin Fhp),
C16 and C17 (both including Pc16g13280, a probable glutathione re-
ductase), C30 (Pc16g09250, probable cytochrome-b5 reductase) and
C48 (Pc18g00790, probable glutathione S-transferase).
3.3.2. Extracellular proteome
The 2-DE gels including the extracellular protein fractions obtained
in the presence and absence of phenylacetic acid were also compared to
each other (Fig. 7). A total of 45 spots, named P1-P45 and including 49
proteins (36 diﬀerent proteins), resulted overrepresented, whereas 14
spots, named S1-S14 and including 16 proteins (12 diﬀerent proteins),
were underrepresented after phenylacetic acid addition (Supplemen-
tary Tables S3 and S4). Secretion of those proteins due to the presence
of classical signal peptides or through a non-classical secretory me-
chanism was predicted as indicated in our previous work [23]. A total
of 38 diﬀerent proteins out of the 48 proteins found diﬀerentially re-
presented in the secretome were predicted to contain either classical or
non-classical signal sequences (Tables 3 and 4) (see Discussion).
Functions were inferred for these proteins and the main ﬁndings are
summarized below.
The most important extracellular protein overrepresented after the
addition of phenylacetic acid is included in spot P16. This spot is only
detected under these conditions and contains the glutamate dehy-
drogenase (encoded by the gdhA gene), which lacks classical or non-
classical signal sequences for secretion (see Discussion).
Some proteins from the glycolysis, tricarboxylic acid cycle and
Fig. 4. Gene silencing of Pc16g01770. A) Southern blot ana-
lysis of diﬀerent transformants (1, 5, 15, 38, 52 and 55) and
the parental P. rubens (P. chrysogenum Wisconsin 54–1255
strain) (Wis). The 473-bp exon fragment (indicated as a black
box inside the corresponding gene) included in the silencing
cassette, was used as probe. All transformants show the 1855-
bp hybridisation band corresponding to the silencing cassette.
Note the presence of the 9423-bp genomic band containing the
endogenous Pc16g01770 gene. Additional hybridisation bands
are likely due to partial digestion of genomic DNA. B) Relative
expression (quantiﬁed by RT-PCR) of Pc16g01770 in diﬀerent
transformants compared to the Wisconsin 54–1255 strain
(Wis; reference value set to 100). Values correspond to the
mean plus standard deviation of three independent experi-
ments. Statistical signiﬁcance by ANOVA test is represented
above error bars as “*” (0.01≤ P < 0.05); “**”
(0.001≤ P < 0.01); “***” (P < 0.001).
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pentose phosphate pathways are also overrepresented under these
conditions, including a probable mitochondrial aconitate hydratase
Aco1 (Pc22g02000, spots P4, P5 and P9), an enolase (Pc14g01740,
spots P18 and P43), and a probable transaldolase Tal1 (Pc21g16950,
spot P26). Interestingly, none of these proteins are predicted to be se-
creted (Table 3) (see Discussion).
All proteins underrepresented in the presence of the benzylpenicillin
side chain precursor are predicted to be secreted (Table 4). Most of
them are involved in plant cell wall and plant tissues degradation. This
is the case of spots S3 and S11 (both including Pc22g20290, a probable
polygalacturonase pgaI), S5 (Pc22g24890, probable pectate lyase plyA,
and Pc20g07020, endo-1,4-beta-xylanase A precursor XylP), S11
(Pc22g20290, probable polygalacturonase pgaI), S12 and S13 (both
including Pc20g07030, a probable 1,4-beta-Δ-arabinoxylan arabino-
furanohydrolase axhA).
The presence of phenylacetic acid downregulates the synthesis of a
probable cephalosporin esterase (Pc12g13400). This wide substrate
spectrum esterase forms deacetylcephalosporin C and acetate using
cephalosporin C as substrate and is included in spot S6 (5.2-fold un-
derrepresented under these conditions).
4. Discussion
One of the most important milestones in the history of penicillins is
the ﬁnding that addition of speciﬁc side chain precursors (e.g. pheny-
lacetic acid) to culture media, directed the biosynthetic process mainly
towards benzylpenicillin (penicillin G) [32], which is the main bio-
synthetic penicillin produced under industrial conditions. Distinct P.
rubens strains behave in a diﬀerent way regarding detoxiﬁcation of
phenylacetic acid. Unlike P. notatum, P. chrysogenum is unable to grow
on phenylacetic acid as sole carbon source, although it can eﬃciently
oxidize it, hence suggesting a block in the catabolic pathway to fuma-
rate and acetoacetate [14, 15]. These authors reported that modiﬁca-
tions (L181F and A394V) in the phenylacetate hydroxylase (the ﬁrst
enzyme of the catabolic pathway of phenylacetic acid) during strain
improvement programs gave rise to loss-of-functions mutations, thus
leading to reduced degradation of phenylacetic acid and to penicillin
overproduction in P. chrysogenum [14, 15]. Our results (Fig. 2) indicate
that in the presence of sucrose and lactose as carbon sources, P. chry-
sogenum is able not only to incorporate phenylacetic acid to the ben-
zylpenicillin biosynthetic pathway, but also to convert it to 2-hydro-
xyphenylacetic acid by the phenylacetate hydroxylase via the
homogentisate pathway. In addition, P. chrysogenum Wisconsin
54–1255 showed an increase in 2-hydroxyphenylacetate levels along
the culture time in comparison with P. notatum and P. chrysogenum
NRRL 1951, which accumulate lower amounts of this compound likely
due to a faster metabolization to 2, 5-dihydroxyphenylacetate at late
time points. This phenomenon is similar to that reported in P. chryso-
genum overproducing strains, where signiﬁcant amounts of 2-hydro-
xyphenylacetic acid are detected in the fermentation broth [15].
Therefore, both detoxiﬁcation mechanisms seem to coexist in diﬀerent
species of P. rubens, but with diﬀerent eﬃciencies. While catabolic
detoxiﬁcation is more eﬃcient in P. notatum and P. chrysogenum NRRL
1951 than in P. chrysogenum Wisconsin 54–1255, detoxiﬁcation by
means of penicillin formation is more eﬃcient in P. chrysogenum Wis-
consin 54–1255 than in the other two strains. The fact that P. chryso-
genum Wisconsin 54–1255 shows catabolic detoxiﬁcation suggests a
partial blockage of phenylacetate hydroxylase activity in improved
strains of P. chrysogenum, or the presence of at least another protein
with phenylacetate hydroxylase activity in this microorganism. This
question can be elucidated by comparison to the information published
for A. nidulans, another penicillin-producing fungus.
A. nidulans, known to degrade eﬃciently phenylacetic acid by dif-
ferent enzymes, is also able to utilize phenylacetate as a carbon source
via homogentisate, phenylacetic acid being converted to 2-hydro-
xyphenylacetate by means of a 2-hydroxylation reaction catalysed by a
cytochrome P450 monooxygenase, which is encoded by the phacA gene
[18]. In addition, the existence of another cytochrome P450 mono-
oxygenase (encoded by the phacB) with 3-hydroxyphenylacetate 6-hy-
droxylase and 3,4-dihydroxyphenylacetate 6-hydroxylase activities that
forms 2,5-dihydroxyphenylacetate (homogentisate) and can also con-
vert phenylacetic acid into 2-hydroxyphenylacetate, has been reported
in this microorganism [20]. Interestingly, we found three proteins
(Pc22g02230, Pc16g01770 and Pc21g22560) from the cytochrome
P450 superfamily that show>50% similarity with the pahA-encoded
protein (Pc21g14280) in the P. rubens (P. chrysogenum Wisconsin
54–1255) genome. Unlike Pc22g02230, Pc16g01770 was expressed
under the conditions tested (Fig. 3). This result is consistent with pre-
vious transcriptomics data, which reported high transcription rate of
Fig. 5. Relative percentage (%) of A) potassium phenylacetate, B) 2-hydro-
xyphenylacetate (2-OH phenylacetate) speciﬁc production and B) benzylpeni-
cillin speciﬁc production assessed in samples obtained at 24 h, 48 h and 72 h
from cultures of P. rubens (P. chrysogenum Wisconsin 54–1255) (W) and dif-
ferent Pc16g01770 knock-down transformants (1, 5, 15 and 38). Results are
represented as the mean ± standard deviation from three independent ex-
periments carried out in triplicate. Values were normalized to those provided by
the Wisconsin 54–1255 strain (W) at each time-point, which were set to 100%.
Statistical signiﬁcance by ANOVA test is represented above error bars as “*”
(0.01≤ P < 0.05).
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Pc16g01770 and transcriptional induction in the presence of phenyla-
cetate. However, Pc21g22560 and Pc22g02230 exhibited null expres-
sion levels and no transcriptional induction under the same conditions
in chemostat cultivations [12]. The protein encoded by Pc16g01770
shows 90% similarity and 82% identity with the A. nidulans phacB-en-
coded cytochrome P450 monooxygenase, suggesting a possible role of
this protein in the formation of 2,5-dihydroxyphenylacetate (homo-
gentisate) and in phenylacetate hydroxylation. The latter was tested by
gene knock-down experiments, where most of the transformants si-
lenced in the expression of Pc16g01770 showed a slight decrease in 2-
hydroxyphenylacetate levels (Fig. 5). These results point to the pre-
sence of at least one additional enzyme, encoded by Pc16g01770, with
residual phenylacetate hydroxylase activity in P. chrysogenum Wis-
consin 54–1255. However, additional experiments (e.g. heterologous
expression, biochemical characterization and analysis of substrate
speciﬁcity) are still required to conﬁrm the role played by the protein
encoded by Pc16g01770 in the homogentisate pathway.
Interestingly, Pc16g01770 and the pahA-encoded phenylacetate
hydroxylase lack a canonical PTS1 signal, which is a target sequence
present at the C terminus that allows import of proteins into peroxi-
somes [33, 34]. Therefore, phenylacetate degradation via the homo-
gentisate pathway by the protein encoded by Pc16g01770 and the
pahA-encoded phenylacetate hydroxylase likely takes place during its
way to the peroxisomal matrix. The transport of phenylacetic acid from
the culture medium to the cytoplasm and then to peroxisomes has been
a matter of discrepancy. Either active transport [35, 36] or passive
diﬀusion [37], have been suggested as mechanisms for internalization
of the benzylpenicillin side-chain precursor. More recently, a process of
two consecutive steps (facilitated diﬀusion in the plasma membrane
and active transport in the peroxisomal membrane) has been suggested
after the characterization of a MFS transporter (PaaT) that participates
in the translocation of phenylacetic acid from the cytosol to the per-
oxisomal lumen across the peroxisomal membrane of P. rubens [38].
Once phenylacetic acid is present within peroxisomes, it is activated by
aryl-CoA ligases and incorporated into the penicillin biosynthetic
pathway. The percentage of phenylacetic acid being incorporated into
either of these two pathways (i.e. catabolism via homogentisate and
benzylpenicillin biosynthesis) seems to be highly dependent on the
strain, as previously suggested [14, 15].
Phenylacetic acid has a clear direct involvement in benzylpenicillin
biosynthesis due to its participation as side chain precursor. In an at-
tempt to characterize other roles that this molecule can play regarding
penicillin production, we decided to carry out a global comparative
proteomics analysis in P. rubens (P. chrysogenum Wisconsin 54–1255)
with and without phenylacetic acid addition. Unexpectedly, only one
protein (fumaryl acetoacetase; Pc12g09030) involved in the catabolism
of the side chain precursor was induced by phenylacetate. Previous
transcriptomics analysis reported that all genes of the homogentisate
pathway for phenylacetate catabolism were strongly upregulated in the
presence of phenylacetic acid [22]. These authors used a high-produ-
cing P. chrysogenum strain grown under glucose-limited chemostat
conditions, which may be one of the main reasons for the upregulation
of the whole catabolic pathway.
Among the intracellular proteins whose synthesis was induced in
the presence of this side chain precursors, there are several enzymes
related to β-lactam biosynthesis. The most important one is IAT
Fig. 6. Eﬀect of phenylacetic acid (PAA) in the intracellular proteome of P. rubens (P. chrysogenum Wisconsin 54–1255). Intracellular proteins obtained from mycelia
of P. rubens (P. chrysogenumWisconsin 54–1255) grown for 60 h in DP medium with and without 1 g/L potassium phenylacetate, were separated by 2-DE using 18-cm
wide-range IPG strips (pH 3–10 NL) and 12.5% SDS-PAGE gels, which were stained with CC following the “Blue Silver” staining method. Those spots overrepresented
without PAA (underrepresented with PAA) are designated as “C”, whereas the letter “D” was used to designate those spots overrepresented in the presence of PAA.
The spots diﬀerentially represented in each condition are numbered and correspond to those proteins listed in Tables 1 (“D” spots) and 2 (“C” spots) and Supple-
mentary Tables S1 (“D” spots) and S2 (“C” spots).
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(Pc21g21370), which is directly involved in the last step of the peni-
cillin biosynthetic pathway and catalyses the replacement of the IPN
side chain by the aromatic aryl side chain provided by the activated
form of phenylacetic acid (i.e. phenylacetyl CoA) [39]. Other important
proteins are a hypothetical cystathionine beta synthase, which is in-
volved in the biosynthesis of cystathionine, a precursor of the cysteine
in the ACV tripeptide [40, 41], a probable ketol-acid reductoisomerase
ilv-2 involved in step 2 of the subpathway that synthesizes L-valine (one
of the three amino acid precursors of penicillin) from pyruvate, and a
probable thioredoxin peroxidase (Pc22g04430), which together with
thioredoxin and thioredoxin reductase, comprise the thioredoxin
system involved in the reduction of bis-ACV (the oxidized disulﬁde
form of ACV) and reincorporation of this molecule to the penicillin
biosynthetic pathway [42]. S-adenosylmethionine synthase also re-
sulted overrepresented after phenylacetate addition. This protein has
been reported to coordinate fungal secondary metabolism and devel-
opment [43] and its overexpression has been related to increased pro-
ductivity of secondary metabolites in bacteria [44, 45].
When the extracellular protein fraction was analysed, we found
some proteins lacking predicted signal sequences for secretion. This
phenomenon has also been previously described in fungi [23, 46],
pointing to these proteins as truly secreted multifunctional proteins
with diﬀerent activities according to their intracellular or extracellular
location, a fact that has been conﬁrmed in other organisms [47].
However, the extracellular presence of these proteins due to cell lysis
events cannot be completely ruled out. One important mechanism in-
volved in penicillin production and triggered by phenylacetic acid can
be related to the induction and ﬁnding of the glutamate dehydrogenase
(encoded by the gdhA gene) in the culture broths. Although this protein
lacks classical or non-classical signal sequences for secretion, an ex-
tracellular form of glutamate dehydrogenase has been reported in other
microorganisms, such as Clostridium diﬃcile, where it confers resistance
to hydrogen peroxide [48]. The protein encoded by the gdhA gene is
NADPH-dependent and catalyses inside the cell the reductive amination
of 2-oxoglutarate, thus giving rise to glutamate by means of a ther-
modynamically and energetically favored pathway for ammonium as-
similation. Interestingly, the NADPH-dependent glutamate dehy-
drogenase has been reported to be involved in regulation of β-lactam
production in industrial strains of P. chrysogenum [49] and therefore, its
presence in the extracellular protein fraction in response to phenyla-
cetic acid addition may represent important information for improved
productivity.
5. Conclusions
These results provide important data about the fate of phenylacetic
acid in P. rubens. In addition to being the side chain precursor of ben-
zylpenicillin, this molecule also plays a positive role in penicillin pro-
duction. This is achieved by means of the eﬀect exerted on some pro-
teins directly related to the biosynthesis of penicillin (IAT, thioredoxin
peroxidase) and precursor amino acids (cystathionine beta synthase,
ketol-acid reductoisomerase ilv-2), and other important proteins
(NADPH-dependent glutamate dehydrogenase, S-adenosylmethionine
synthase). This information contributes to the knowledge of the mole-
cular mechanisms interconnected with phenylacetate utilization and
penicillin biosynthesis in penicillin-producing strains of P. rubens.
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Fig. 7. Eﬀect of phenylacetic acid (PAA) in the extracellular proteome of P. rubens (P. chrysogenum Wisconsin 54–1255). Extracellular proteins obtained from culture
supernatants of P. rubens (P. chrysogenum Wisconsin 54–1255) grown for 60 h in DP medium with and without 1 g/L potassium phenylacetate, were separated by 2-
DE using 18-cm wide-range IPG strips (pH 4–7 NL) and 12.5% SDS-PAGE gels, which were stained with CC following the “Blue Silver” staining method. Those spots
overrepresented without PAA (underrepresented with PAA) are designated as “S”, whereas the letter “P” was used to designate those spots overrepresented in the
presence of PAA. The spots diﬀerentially represented in each condition are numbered and correspond to those proteins listed in Tables 3 (“P” spots) and 4 (“S” spots)
and Supplementary Tables S3 (“P” spots) and S4 (“S” spots).
M.-S. Jami et al. Journal of Proteomics 187 (2018) 243–259
255
Ta
bl
e
3
Ex
tr
ac
el
lu
la
r
pr
ot
ei
ns
ov
er
re
pr
es
en
te
d
at
60
h
in
th
e
pr
es
en
ce
of
ph
en
yl
ac
et
ic
ac
id
.F
ol
d
in
cr
ea
se
an
d
p-
va
lu
e
ar
e
in
di
ca
te
d.
Pr
ot
ei
ns
th
at
ar
e
on
ly
de
te
ct
ed
af
te
r
th
e
ad
di
ti
on
of
ph
en
yl
ac
et
ic
ac
id
ar
e
de
no
te
d
as
N
/A
.
Sp
ot
O
R
F
A
cc
es
si
on
N
o
Si
m
ila
ri
ty
Fo
ld
ch
an
ge
P-
V
al
ue
Fu
nc
ti
on
Si
gn
al
pe
pt
id
e
N
on
-c
la
ss
ic
al
ly
se
cr
et
ed
pr
ot
ei
n
P1
Pc
18
g0
29
00
gi
|2
11
58
68
64
ly
so
ph
os
ph
ol
ip
as
e
ph
os
ph
ol
ip
as
e
B
pl
b1
-P
en
ic
ill
iu
m
ch
ry
so
ge
nu
m
N
/A
N
/A
G
ly
ce
ro
ph
os
ph
ol
ip
id
m
et
ab
ol
is
m
Y
ES
P2
Pc
22
g0
64
90
gi
|2
11
59
16
94
st
ro
ng
si
m
ila
ri
ty
to
al
ka
lin
e
ph
os
ph
at
as
e
-N
eu
ro
sp
or
a
cr
as
sa
N
/A
N
/A
D
ep
ho
sp
ho
ry
la
ti
on
Y
ES
P3
Pc
22
g0
64
90
gi
|2
11
59
16
94
st
ro
ng
si
m
ila
ri
ty
to
al
ka
lin
e
ph
os
ph
at
as
e
-N
eu
ro
sp
or
a
cr
as
sa
N
/A
N
/A
D
ep
ho
sp
ho
ry
la
ti
on
Y
ES
P4
Pc
22
g0
20
00
gi
|2
11
59
12
61
st
ro
ng
si
m
ila
ri
ty
to
m
it
oc
ho
nd
ri
al
ac
on
it
at
e
hy
dr
at
as
e
A
co
1
-
Sa
cc
ha
ro
m
yc
es
ce
re
vi
si
ae
N
/A
N
/A
C
it
ri
c
ac
id
cy
cl
e
N
O
N
O
P5
Pc
22
g0
20
00
gi
|2
11
59
12
61
st
ro
ng
si
m
ila
ri
ty
to
m
it
oc
ho
nd
ri
al
ac
on
it
at
e
hy
dr
at
as
e
A
co
1
-
Sa
cc
ha
ro
m
yc
es
ce
re
vi
si
ae
N
/A
N
/A
C
it
ri
c
ac
id
cy
cl
e
N
O
N
O
P6
Pc
22
g0
93
80
gi
|2
11
59
19
67
st
ro
ng
si
m
ila
ri
ty
to
gl
yc
os
yl
ph
os
ph
at
id
yl
in
os
it
ol
-a
nc
ho
re
d
be
ta
(1
–3
)g
lu
ca
no
sy
lt
ra
ns
fe
ra
se
ge
l3
-
A
sp
er
gi
llu
s
fu
m
ig
at
us
3.
7
1.
0E
-0
4
C
el
l
w
al
l
m
or
ph
og
en
es
is
Y
ES
P7
Pc
22
g0
28
00
gi
|2
11
59
13
41
st
ro
ng
si
m
ila
ri
ty
to
ca
lc
iu
m
-b
in
di
ng
pr
ot
ei
n
pr
ec
ur
so
r
cn
x1
p
-
Sc
hi
zo
sa
cc
ha
ro
m
yc
es
po
m
be
N
/A
N
/A
C
on
tr
ol
of
ce
llu
la
r
fu
nc
ti
on
s
Y
ES
Pc
22
g1
65
10
gi
|2
11
59
25
82
st
ro
ng
si
m
ila
ri
ty
to
is
oa
m
yl
al
co
ho
l
ox
id
as
e
m
re
A
-
A
sp
er
gi
llu
s
or
yz
ae
N
/A
N
/A
Fo
rm
at
io
n
of
is
ov
al
er
al
de
hy
de
Y
ES
P8
Pc
22
g0
28
00
gi
|2
11
59
13
41
st
ro
ng
si
m
ila
ri
ty
to
ca
lc
iu
m
-b
in
di
ng
pr
ot
ei
n
pr
ec
ur
so
r
cn
x1
p
-
Sc
hi
zo
sa
cc
ha
ro
m
yc
es
po
m
be
N
/A
N
/A
C
on
tr
ol
of
ce
llu
la
r
fu
nc
ti
on
s
Y
ES
P9
Pc
22
g0
20
00
gi
|2
11
59
12
61
st
ro
ng
si
m
ila
ri
ty
to
m
it
oc
ho
nd
ri
al
ac
on
it
at
e
hy
dr
at
as
e
A
co
1
-
Sa
cc
ha
ro
m
yc
es
ce
re
vi
si
ae
N
/A
N
/A
C
it
ri
c
ac
id
cy
cl
e
N
O
N
O
P1
0
Pc
22
g2
27
10
gi
|2
11
59
31
82
st
ro
ng
si
m
ila
ri
ty
to
di
hy
dr
ox
y-
ac
id
de
hy
dr
at
as
e
Il
v3
-
Sa
cc
ha
ro
m
yc
es
ce
re
vi
si
ae
N
/A
N
/A
Bi
os
yn
th
es
is
of
br
an
ch
ed
-c
ha
in
am
in
o
ac
id
s
N
O
Y
ES
P1
1
Pc
22
g0
93
90
gi
|2
11
59
19
68
st
ro
ng
si
m
ila
ri
ty
to
m
an
ni
to
l
de
hy
dr
og
en
as
e
m
tl
D
-
Ps
eu
do
m
on
as
ﬂ
uo
re
sc
en
s
N
/A
N
/A
Fr
uc
to
se
an
d
m
an
no
se
m
et
ab
ol
is
m
N
O
N
O
Pc
18
g0
13
90
gi
|2
11
58
67
17
st
ro
ng
si
m
ila
ri
ty
to
ph
os
ph
og
lu
co
m
ut
as
e
pg
m
B
-
A
sp
er
gi
llu
s
ni
du
la
ns
N
/A
N
/A
H
ex
os
e
m
et
ab
ol
is
m
N
O
Y
ES
P1
2
Pc
18
g0
09
80
gi
|2
11
58
66
77
st
ro
ng
si
m
ila
ri
ty
to
hy
po
th
et
ic
al
tr
un
k
la
te
ra
l
ce
ll
sp
ec
iﬁ
c
ge
ne
H
rT
LC
1
-
H
al
oc
yn
th
ia
ro
re
tz
i
N
/A
N
/A
R
ed
ox
m
et
ab
ol
is
m
N
O
Y
ES
P1
3
Pc
18
g0
09
80
gi
|2
11
58
66
77
st
ro
ng
si
m
ila
ri
ty
to
hy
po
th
et
ic
al
tr
un
k
la
te
ra
l
ce
ll
sp
ec
iﬁ
c
ge
ne
H
rT
LC
1
-
H
al
oc
yn
th
ia
ro
re
tz
i
N
/A
N
/A
R
ed
ox
m
et
ab
ol
is
m
N
O
Y
ES
P1
4
Pc
20
g0
47
20
gi
|2
11
58
77
49
st
ro
ng
si
m
ila
ri
ty
to
pr
ec
ur
so
r
of
di
hy
dr
ol
ip
oa
m
id
e
de
hy
dr
og
en
as
e
Lp
d1
-
Sa
cc
ha
ro
m
yc
es
ce
re
vi
si
ae
N
/A
N
/A
E3
co
m
po
ne
nt
of
th
e
py
ru
va
te
,α
-k
et
og
lu
ta
ra
te
,a
nd
br
an
ch
ed
-c
ha
in
am
in
o
ac
id
-d
eh
yd
ro
ge
na
se
co
m
pl
ex
es
an
d
th
e
gl
yc
in
e
cl
ea
va
ge
sy
st
em
N
O
Y
ES
P1
5
Pc
18
g0
13
90
gi
|2
11
58
67
17
st
ro
ng
si
m
ila
ri
ty
to
ph
os
ph
og
lu
co
m
ut
as
e
pg
m
B
-
A
sp
er
gi
llu
s
ni
du
la
ns
2.
6
1.
3E
-0
6
H
ex
os
e
m
et
ab
ol
is
m
N
O
Y
ES
P1
6
Pc
22
g1
75
60
gi
|2
11
59
26
84
gl
ut
am
at
e
de
hy
dr
og
en
as
e
gd
hA
-P
en
ic
ill
iu
m
ch
ry
so
ge
nu
m
N
/A
N
/A
A
m
m
on
iu
m
ut
ili
za
ti
on
.
R
eg
ul
at
io
n
of
be
ta
-la
ct
am
pr
od
uc
ti
on
N
O
N
O
P1
7
Pc
18
g0
13
90
gi
|2
11
58
67
17
st
ro
ng
si
m
ila
ri
ty
to
ph
os
ph
og
lu
co
m
ut
as
e
pg
m
B
-
A
sp
er
gi
llu
s
ni
du
la
ns
3.
4
1.
8E
-0
4
H
ex
os
e
m
et
ab
ol
is
m
N
O
Y
ES
P1
8
Pc
14
g0
17
40
gi
|2
11
58
47
89
en
ol
as
e
BA
C
82
54
9-
Pe
ni
ci
lli
um
ch
ry
so
ge
nu
m
N
/A
N
/A
G
ly
co
ly
si
s
N
O
N
O
P1
9
Pc
20
g0
36
10
gi
|2
11
58
76
47
st
ro
ng
si
m
ila
ri
ty
to
pr
ec
ur
so
r
of
m
it
oc
ho
nd
ri
al
is
oc
it
ra
te
de
hy
dr
og
en
as
e
ic
dA
-
A
sp
er
gi
llu
s
ni
ge
r
N
/A
N
/A
C
it
ri
c
ac
id
cy
cl
e
N
O
Y
ES
P2
0
Pc
16
g0
50
80
gi
|2
11
58
54
78
st
ro
ng
si
m
ila
ri
ty
to
ad
en
os
yl
ho
m
oc
ys
te
in
as
e
-H
om
o
sa
pi
en
s
N
/A
N
/A
M
et
hy
la
ti
on
cy
cl
e
N
O
Y
ES
P2
1
Pc
12
g1
48
60
gi
|2
11
58
29
09
ex
tr
ac
el
lu
la
r
ac
id
ph
os
ph
at
as
e
Ph
oA
-P
en
ic
ill
iu
m
ch
ry
so
ge
nu
m
16
.1
3.
5E
-0
4
D
ep
ho
sp
ho
ry
la
ti
on
Y
ES
P2
2
Pc
12
g0
43
10
gi
|2
11
58
19
20
st
ro
ng
si
m
ila
ri
ty
to
ac
et
at
e-
in
du
ci
bl
e
ge
ne
ac
iA
-
A
sp
er
gi
llu
s
ni
du
la
ns
N
/A
N
/A
O
xi
da
ti
on
of
fo
rm
at
e.
Fo
rm
at
io
n
of
en
er
gy
N
O
Y
ES
P2
3
Pc
12
g0
43
10
gi
|2
11
58
19
20
st
ro
ng
si
m
ila
ri
ty
to
ac
et
at
e-
in
du
ci
bl
e
ge
ne
ac
iA
-
A
sp
er
gi
llu
s
ni
du
la
ns
N
/A
N
/A
O
xi
da
ti
on
of
fo
rm
at
e.
Fo
rm
at
io
n
of
en
er
gy
N
O
Y
ES
P2
4
Pc
16
g0
27
90
gi
|2
11
58
52
72
st
ro
ng
si
m
ila
ri
ty
to
as
pa
rt
at
e
tr
an
sa
m
in
as
e
lik
e
pr
ot
ei
n
A
n0
8g
01
00
0
-
A
sp
er
gi
llu
s
ni
ge
r
N
/A
N
/A
A
m
in
o
ac
id
m
et
ab
ol
is
m
N
O
Y
ES
P2
5
Pc
22
g0
48
50
gi
|2
11
59
15
39
st
ro
ng
si
m
ila
ri
ty
to
D
-a
ra
bi
no
se
de
hy
dr
og
en
as
e
A
ra
1
-
Sa
cc
ha
ro
m
yc
es
ce
re
vi
si
ae
N
/A
N
/A
O
xi
do
re
du
ct
as
e
ac
ti
vi
ty
N
O
N
O
P2
6
Pc
21
g1
69
50
gi
|2
11
59
04
06
st
ro
ng
si
m
ila
ri
ty
to
tr
an
sa
ld
ol
as
e
Ta
l1
-S
ac
ch
ar
om
yc
es
ce
re
vi
si
ae
N
/A
N
/A
Pe
nt
os
e
ph
os
ph
at
e
pa
th
w
ay
N
O
N
O
P2
7
Pc
21
g1
69
50
gi
|2
11
59
04
06
st
ro
ng
si
m
ila
ri
ty
to
tr
an
sa
ld
ol
as
e
Ta
l1
-S
ac
ch
ar
om
yc
es
ce
re
vi
si
ae
N
/A
N
/A
Pe
nt
os
e
ph
os
ph
at
e
pa
th
w
ay
N
O
N
O
P2
8
Pc
20
g0
72
30
gi
|2
11
58
79
83
st
ro
ng
si
m
ila
ri
ty
to
in
or
ga
ni
c
py
ro
ph
os
ph
at
as
e
Ip
p1
-
Sa
cc
ha
ro
m
yc
es
ce
re
vi
si
ae
N
/A
N
/A
G
en
er
al
m
et
ab
ol
is
m
N
O
N
O
(c
on
tin
ue
d
on
ne
xt
pa
ge
)
M.-S. Jami et al. Journal of Proteomics 187 (2018) 243–259
256
Ta
bl
e
3
(c
on
tin
ue
d)
Sp
ot
O
R
F
A
cc
es
si
on
N
o
Si
m
ila
ri
ty
Fo
ld
ch
an
ge
P-
V
al
ue
Fu
nc
ti
on
Si
gn
al
pe
pt
id
e
N
on
-c
la
ss
ic
al
ly
se
cr
et
ed
pr
ot
ei
n
P2
9
Pc
18
g0
27
40
gi
|2
11
58
68
48
st
ro
ng
si
m
ila
ri
ty
to
re
gu
ca
lc
in
al
so
kn
ow
n
as
se
ne
sc
en
ce
m
ar
ke
r
pr
ot
ei
n-
30
lik
e
pr
ot
ei
n
A
n0
4g
03
42
0
-A
sp
er
gi
llu
s
ni
ge
r
N
/A
N
/A
C
on
tr
ol
of
ce
llu
la
r
fu
nc
ti
on
s
N
O
N
O
Pc
13
g0
87
30
gi
|2
11
58
39
18
st
ro
ng
si
m
ila
ri
ty
to
1,
3-
be
ta
-g
lu
ca
no
sy
lt
ra
ns
fe
ra
se
bg
t1
-A
sp
er
gi
llu
s
fu
m
ig
at
us
N
/A
N
/A
C
el
l
w
al
l
m
or
ph
og
en
es
is
Y
ES
P3
0
Pc
12
g0
58
20
gi
|2
11
58
20
45
st
ro
ng
si
m
ila
ri
ty
to
es
te
ra
se
D
ES
D
-
H
om
o
sa
pi
en
s
N
/A
N
/A
G
en
er
al
m
et
ab
ol
is
m
N
O
Y
ES
P3
1
Pc
13
g0
44
20
gi
|2
11
58
34
97
or
ot
id
in
e
5-
ph
os
ph
at
e
de
ca
rb
ox
yl
as
e
py
rG
-P
en
ic
ill
iu
m
ch
ry
so
ge
nu
m
N
/A
N
/A
U
ri
di
ne
bi
os
yn
th
es
is
N
O
Y
ES
P3
2
Pc
22
g2
54
70
gi
|2
11
59
34
49
st
ro
ng
si
m
ila
ri
ty
to
So
l1
-
Sa
cc
ha
ro
m
yc
es
ce
re
vi
si
ae
N
/A
N
/A
G
en
er
al
m
et
ab
ol
is
m
N
O
Y
ES
P3
3
Pc
12
g0
08
30
gi
|2
11
58
16
03
st
ro
ng
si
m
ila
ri
ty
to
so
rb
it
ol
ut
ili
za
ti
on
pr
ot
ei
n
so
u2
-
C
an
di
da
al
bi
ca
ns
N
/A
N
/A
C
ar
bo
hy
dr
at
e
M
et
ab
ol
is
m
.
(R
el
at
ed
to
sh
or
t-
ch
ai
n
al
co
ho
l
de
hy
dr
og
en
as
es
)
N
O
N
O
P3
4
Pc
22
g2
22
90
gi
|2
11
59
31
41
st
ro
ng
si
m
ila
ri
ty
to
Ig
E-
bi
nd
in
g
pr
ot
ei
n
-A
sp
er
gi
llu
s
fu
m
ig
at
us
N
/A
N
/A
U
nk
no
w
n
Y
ES
P3
5
Pc
12
g0
08
30
gi
|2
11
58
16
03
st
ro
ng
si
m
ila
ri
ty
to
so
rb
it
ol
ut
ili
za
ti
on
pr
ot
ei
n
so
u2
-
C
an
di
da
al
bi
ca
ns
N
/A
N
/A
C
ar
bo
hy
dr
at
e
M
et
ab
ol
is
m
.
(R
el
at
ed
to
sh
or
t-
ch
ai
n
al
co
ho
l
de
hy
dr
og
en
as
es
)
N
O
N
O
P3
6
Pc
12
g1
36
00
gi
|2
11
58
27
86
st
ro
ng
si
m
ila
ri
ty
to
hy
po
th
et
ic
al
ne
cr
os
is
an
d
et
hy
le
ne
in
du
ci
ng
pr
ot
ei
n
BH
03
95
-
Ba
ci
llu
s
ha
lo
du
ra
ns
N
/A
N
/A
Pr
od
uc
es
Im
m
un
e
re
sp
on
se
s
an
d
ce
ll
de
at
h
in
pl
an
ts
Y
ES
Pc
22
g2
22
90
gi
|2
11
59
31
41
st
ro
ng
si
m
ila
ri
ty
to
Ig
E-
bi
nd
in
g
pr
ot
ei
n
-A
sp
er
gi
llu
s
fu
m
ig
at
us
N
/A
N
/A
U
nk
no
w
n
Y
ES
P3
7
Pc
20
g0
48
10
gi
|2
11
58
77
57
st
ro
ng
si
m
ila
ri
ty
to
es
tr
og
en
re
ce
pt
or
-b
in
di
ng
cy
cl
op
hi
lin
cy
pD
-B
os
pr
im
ig
en
iu
s
ta
ur
us
N
/A
N
/A
C
on
tr
ol
of
ce
llu
la
r
fu
nc
ti
on
s
N
O
N
O
P3
8
Pc
21
g1
42
20
gi
|2
11
59
01
48
st
ro
ng
si
m
ila
ri
ty
to
hy
po
th
et
ic
al
pr
ot
ei
n
co
nt
ig
14
95
_2
.tf
a_
63
0c
g
-
A
sp
er
gi
llu
s
fu
m
ig
at
us
N
/A
N
/A
U
nk
no
w
n
Y
ES
P3
9
Pc
21
g1
25
90
gi
|2
11
58
99
97
si
m
ila
ri
ty
to
6-
hy
dr
ox
y-
D
-n
ic
ot
in
e
ox
id
as
e
6-
H
D
N
O
-
A
rt
hr
ob
ac
te
r
ox
id
an
s
N
/A
N
/A
O
xi
do
re
du
ct
as
e
ac
ti
vi
ty
Y
ES
Pc
21
g0
21
10
gi
|2
11
58
89
87
st
ro
ng
si
m
ila
ri
ty
to
hy
po
th
et
ic
al
pr
ot
ei
n
m
g0
13
87
.1
-
M
ag
na
po
rt
he
gr
is
ea
N
/A
N
/A
U
nk
no
w
n
Y
ES
P4
0
Pc
12
g1
00
10
gi
|2
11
58
24
45
st
ro
ng
si
m
ila
ri
ty
to
pr
ot
ei
n
co
pp
er
re
gu
la
te
d
-
A
sp
er
gi
llu
s
ni
du
la
ns
N
/A
N
/A
U
nk
no
w
n
Y
ES
P4
1
Pc
22
g0
96
80
gi
|2
11
59
19
95
si
m
ila
ri
ty
to
hy
po
th
et
ic
al
pr
ot
ei
n
PA
42
04
-
Ps
eu
do
m
on
as
ae
ru
gi
no
sa
9.
9
6.
3E
-0
5
U
nk
no
w
n
Y
ES
P4
2
gi
|1
44
,9
52
,7
98
16
kD
a
al
le
rg
en
[P
en
ic
ill
iu
m
ch
ry
so
ge
nu
m
]
N
/A
N
/A
U
nk
no
w
n
Y
ES
P4
3
Pc
14
g0
17
40
gi
|2
11
58
47
89
en
ol
as
e
BA
C
82
54
9-
Pe
ni
ci
lli
um
ch
ry
so
ge
nu
m
11
.5
4.
3E
-0
6
G
ly
co
ly
si
s
N
O
N
O
P4
4
Pc
22
g0
58
80
gi
|2
11
59
16
37
st
ro
ng
si
m
ila
ri
ty
to
hy
po
th
et
ic
al
pr
ot
ei
n
11
17
_s
ca
ﬀ
ol
d_
1.
tf
a_
30
0c
g
-
Fu
sa
ri
um
gr
am
in
ea
ru
m
2.
3
2.
8E
-0
4
U
nk
no
w
n
Y
ES
P4
5
Pc
22
g0
01
90
gi
|2
11
59
10
82
st
ro
ng
si
m
ila
ri
ty
to
hy
po
th
et
ic
al
ce
ll
w
al
lp
ro
te
in
bi
nB
-
A
sp
er
gi
llu
s
ni
du
la
ns
N
/A
N
/A
U
nk
no
w
n
Y
ES
M.-S. Jami et al. Journal of Proteomics 187 (2018) 243–259
257
León (ORDEN EDU/1204/2010) co-ﬁnanced by the Fondo Social
Europeo. M.F. Vasco-Cárdenas was granted a MAEC-AECID (II.E) fel-
lowship from Ministry of Foreign Aﬀairs through the Spanish Agency
for International Cooperation (AECID). Authors wish to thank B.
Martín, J. Merino, C. Sánchez and C. Rodríguez for their excellent
technical assistance.
Appendix A. Supplementary data
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.jprot.2018.08.006.
References
[1] G. Hersbach, C. Van der Beek, P. Van Dijck, The penicillins: properties, biosynthesis,
and fermentation, in: E. Vandamme (Ed.), Biotechnol. Ind. Antibiot. Drugs Pharm.
Sci, Vol. 22 Marcel Dekker, New York, 1984, pp. 45–140.
[2] J. Houbraken, J.C. Frisvad, R.A. Samson', Fleming's penicillin producing strain is
not Penicillium chrysogenum but P. rubens, IMA Fungus 2 (2011) 87–95, https://doi.
org/10.5598/imafungus.2011.02.01.12.
[3] J. Martín, P. Liras, Insights into the structure and molecular mechanisms of β-
lactam synthesizing enzymes in fungi, in: G. Brahmachati, A. Demain, J. Adrio
(Eds.), Biotechnology of Microbial Enzymes, Elsevier, NewYork, 2016, pp. 215–241.
[4] J.F. Martín, R.V. Ullán, C. García-Estrada, Regulation and compartmentalization of
β-lactam biosynthesis, Microb. Biotechnol. 3 (2010) 285–299, https://doi.org/10.
1111/j.1751-7915.2009.00123.x.
[5] C. García-Estrada, J.-F. Martín, Penicillins, in: J.F. Martin, C. García-Estrada,
S. Zeilinger (Eds.), Biosynthesis and Molelcular Genetics of Fungal Secondary
Metabolism, vol I, Springer US, New York, 2014, pp. 17–42.
[6] M. Lamas-Maceiras, I. Vaca, E. Rodríguez, J. Casqueiro, J.F. Martín, Ampliﬁcation
and disruption of the phenylacetyl-CoA ligase gene of Penicillium chrysogenum
encoding an aryl-capping enzyme that supplies phenylacetic acid to the iso-
penicillin N-acyltransferase, Biochem. J. 395 (2006) 147–155, https://doi.org/10.
1042/BJ20051599.
[7] F.-Q. Wang, J. Liu, M. Dai, Z.-H. Ren, C.-Y. Su, J.-G. He, Molecular cloning and
functional identiﬁcation of a novel phenylacetyl-CoA ligase gene from Penicillium
chrysogenum, Biochem. Biophys. Res. Commun. 360 (2007) 453–458, https://doi.
org/10.1016/j.bbrc.2007.06.074.
[8] M.J. Koetsier, A.K. Gombert, S. Fekken, R.A.L. Bovenberg, M.A. van den Berg,
J.A.K.W. Kiel, P.A. Jekel, D.B. Janssen, J.T. Pronk, I.J. van der Klei, J.-M. Daran,
The Penicillium chrysogenum aclA gene encodes a broad-substrate-speciﬁcity acyl-
coenzyme A ligase involved in activation of adipic acid, a side-chain precursor for
cephem antibiotics, Fungal Genet. Biol. 47 (2010) 33–42, https://doi.org/10.1016/
j.fgb.2009.10.003.
[9] Z.-L. Yu, J. Liu, F.-Q. Wang, M. Dai, B.-H. Zhao, J.-G. He, H. Zhang, Cloning and
characterization of a novel CoA-ligase gene from Penicillium chrysogenum, Folia
Microbiol. Praha 56 (2011) 246–252, https://doi.org/10.1007/s12223-011-0044-y.
[10] F. Fierro, J.L. Barredo, B. Díez, S. Gutierrez, F.J. Fernández, J.F. Martín, The pe-
nicillin gene cluster is ampliﬁed in tandem repeats linked by conserved hex-
anucleotide sequences, Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 6200–6204 http://
www.ncbi.nlm.nih.gov/pubmed/7597101 , Accessed date: 12 May 2018.
[11] W.H. Müller, T.P. van der Krift, A.J. Krouwer, H.A. Wösten, L.H. van der Voort,
E.B. Smaal, A.J. Verkleij, Localization of the pathway of the penicillin biosynthesis
in Penicillium chrysogenum, EMBO J. 10 (1991) 489–495 http://www.ncbi.nlm.
nih.gov/pubmed/1899377 , Accessed date: 12 May 2018.
[12] M.A. van den Berg, R. Albang, K. Albermann, J.H. Badger, J.-M. Daran,
A.J.M. Driessen, C. Garcia-Estrada, N.D. Fedorova, D.M. Harris, W.H.M. Heijne,
V. Joardar, J.A.K.W. Kiel, A. Kovalchuk, J.F. Martín, W.C. Nierman, J.G. Nijland,
J.T. Pronk, J.A. Roubos, I.J. van der Klei, N.N.M.E. van Peij, M. Veenhuis, H. von
Döhren, C. Wagner, J. Wortman, R.A.L. Bovenberg, Genome sequencing and ana-
lysis of the ﬁlamentous fungus Penicillium chrysogenum, Nat. Biotechnol. 26
(2008) 1161–1168, https://doi.org/10.1038/nbt.1498.
[13] M.-S. Jami, C. Barreiro, C. García-Estrada, J.-F. Martín, Proteome analysis of the
penicillin producer Penicillium chrysogenum: characterization of protein changes
during the industrial strain improvement, Mol. Cell. Proteomics 9 (2010)
1182–1198, https://doi.org/10.1074/mcp.M900327-MCP200.
[14] M. Rodríguez-Sáiz, J.L. Barredo, M.A. Moreno, J.M. Fernández-Cañón,
M.A. Peñalva, B. Díez, Reduced function of a phenylacetate-oxidizing cytochrome
p450 caused strong genetic improvement in early phylogeny of penicillin-producing
strains, J. Bacteriol. 183 (2001) 5465–5471, https://doi.org/10.1128/JB.183.19.
5465-5471.2001.
[15] M. Rodríguez-Sáiz, B. Díez, J.L. Barredo, Why did the Fleming strain fail in peni-
cillin industry? Fungal Genet. Biol. 42 (2005) 464–470, https://doi.org/10.1016/j.
fgb.2005.01.014.
[16] J.M. Fernández-Cañón, M.A. Peñalva, Molecular characterization of a gene en-
coding a homogentisate dioxygenase from aspergillus nidulans and identiﬁcation of
its human and plant homologues, J. Biol. Chem. 270 (1995) 21199–21205 http://
www.ncbi.nlm.nih.gov/pubmed/7673153 , Accessed date: 12 May 2018.
[17] J.M. Fernández-Cañón, M.A. Peñalva, Fungal metabolic model for human type I
hereditary tyrosinaemia, Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 9132–9136
http://www.ncbi.nlm.nih.gov/pubmed/7568087 , Accessed date: 12 May 2018.
Ta
bl
e
4
Ex
tr
ac
el
lu
la
r
pr
ot
ei
ns
un
de
rr
ep
re
se
nt
ed
at
60
h
in
th
e
pr
es
en
ce
of
ph
en
yl
ac
et
ic
ac
id
.F
ol
d
de
cr
ea
se
an
d
p-
va
lu
e
ar
e
in
di
ca
te
d.
Pr
ot
ei
ns
th
at
ar
e
no
t
de
te
ct
ed
af
te
r
th
e
ad
di
ti
on
of
ph
en
yl
ac
et
ic
ac
id
ar
e
de
no
te
d
as
N
/A
.
Sp
ot
O
R
F
A
cc
es
si
on
N
o
Si
m
ila
ri
ty
Fo
ld
ch
an
ge
P-
V
al
ue
Fu
nc
ti
on
Si
gn
al
pe
pt
id
e
N
on
-c
la
ss
ic
al
ly
se
cr
et
ed
pr
ot
ei
n
S1
Pc
22
g1
78
70
gi
|2
11
59
27
13
st
ro
ng
si
m
ila
ri
ty
to
hy
po
th
et
ic
al
EC
M
33
ho
m
ol
og
SP
C
C
12
23
.1
2c
-
Sc
hi
zo
sa
cc
ha
ro
m
yc
es
po
m
be
−
2.
9
5.
4E
-0
6
U
nk
no
w
n
Y
ES
S2
Pc
21
g2
32
10
gi
|2
11
59
09
99
st
ro
ng
si
m
ila
ri
ty
to
ce
ll
w
al
l
pr
ot
ei
n
C
rh
1
-S
ac
ch
ar
om
yc
es
ce
re
vi
si
ae
−
4.
6
7.
1E
-0
4
C
el
l
w
al
l
m
or
ph
og
en
es
is
Y
ES
S3
Pc
22
g2
02
90
gi
|2
11
59
29
46
st
ro
ng
si
m
ila
ri
ty
to
po
ly
ga
la
ct
ur
on
as
e
pg
aI
-A
sp
er
gi
llu
s
ni
ge
r
−
6.
3
4.
2E
-0
5
Pl
an
t
ce
ll
w
al
l
de
gr
ad
at
io
n
Y
ES
S4
Pc
22
g1
31
30
gi
|2
11
59
22
57
st
ro
ng
si
m
ila
ri
ty
to
m
it
oc
ho
nd
ri
al
as
pa
rt
at
e
am
in
ot
ra
ns
fe
ra
se
m
A
sp
A
T
-
M
us
m
us
cu
lu
s
−
3.
6
4.
0E
-0
5
A
m
in
o
ac
id
m
et
ab
ol
is
m
N
O
Y
ES
S5
Pc
22
g2
48
90
gi
|2
11
59
33
94
st
ro
ng
si
m
ila
ri
ty
to
pe
ct
at
e
ly
as
e
pl
yA
-A
sp
er
gi
llu
s
ni
ge
r
−
5.
0
4.
7E
-0
5
Pl
an
t
ce
ll
w
al
l
de
gr
ad
at
io
n
Y
ES
Pc
12
g0
78
20
gi
|2
11
58
22
35
si
m
ila
ri
ty
to
ch
it
os
an
as
e
cs
nA
-
A
sp
er
gi
llu
s
or
yz
ae
−
5.
0
4.
7E
-0
5
C
el
l
w
al
l
m
or
ph
og
en
es
is
Y
ES
Pc
20
g0
70
20
gi
|2
11
58
79
62
en
do
-1
,4
-b
et
a-
xy
la
na
se
A
pr
ec
ur
so
r
X
yl
P-
Pe
ni
ci
lli
um
ch
ry
so
ge
nu
m
−
5.
0
4.
7E
-0
5
Pl
an
t
ce
ll
w
al
l
de
gr
ad
at
io
n
Y
ES
S6
Pc
12
g1
34
00
gi
|2
11
58
27
67
st
ro
ng
si
m
ila
ri
ty
to
ce
ph
al
os
po
ri
n
es
te
ra
se
-R
ho
do
sp
or
id
iu
m
to
ru
lo
id
es
−
5.
2
1.
4E
-0
3
Es
te
ra
se
ac
ti
vi
ty
Y
ES
S7
Pc
12
g0
13
30
gi
|2
11
58
16
51
st
ro
ng
si
m
ila
ri
ty
to
hy
po
th
et
ic
al
pr
ot
ei
n
co
nt
ig
31
_p
ar
t_
ii.
tf
a_
13
60
w
g
-
A
sp
er
gi
llu
s
fu
m
ig
at
us
−
8.
0
1.
3E
-0
4
U
nk
no
w
n
Y
ES
S8
Pc
22
g1
78
70
gi
|2
11
59
27
13
st
ro
ng
si
m
ila
ri
ty
to
hy
po
th
et
ic
al
EC
M
33
ho
m
ol
og
SP
C
C
12
23
.1
2c
-
Sc
hi
zo
sa
cc
ha
ro
m
yc
es
po
m
be
−
2.
0
6.
5E
-0
5
U
nk
no
w
n
Y
ES
S9
Pc
22
g2
28
10
gi
|2
11
59
31
92
st
ro
ng
si
m
ila
ri
ty
to
su
lp
hy
dr
yl
ox
id
as
e
So
x
fr
om
pa
te
nt
EP
56
51
72
-A
1
-
A
sp
er
gi
llu
s
ni
ge
r
−
2.
0
6.
3E
-0
4
O
xi
da
ti
on
of
su
lf
hy
dr
yl
co
m
po
un
ds
Y
ES
S1
0
Pc
22
g2
28
10
gi
|2
11
59
31
92
st
ro
ng
si
m
ila
ri
ty
to
su
lp
hy
dr
yl
ox
id
as
e
So
x
fr
om
pa
te
nt
EP
56
51
72
-A
1
-
A
sp
er
gi
llu
s
ni
ge
r
−
2.
2
4.
9E
-0
3
O
xi
da
ti
on
of
su
lf
hy
dr
yl
co
m
po
un
ds
Y
ES
S1
1
Pc
22
g2
02
90
gi
|2
11
59
29
46
st
ro
ng
si
m
ila
ri
ty
to
po
ly
ga
la
ct
ur
on
as
e
pg
aI
-A
sp
er
gi
llu
s
ni
ge
r
N
/A
N
/A
Pl
an
t
ce
ll
w
al
l
de
gr
ad
at
io
n
Y
ES
S1
2
Pc
20
g0
70
30
gi
|2
11
58
79
63
st
ro
ng
si
m
ila
ri
ty
to
1,
4-
be
ta
-Δ
-a
ra
bi
no
xy
la
n
ar
ab
in
of
ur
an
oh
yd
ro
la
se
ax
hA
-
A
sp
er
gi
llu
s
ni
ge
r
−
6.
9
1.
6E
-0
3
Pl
an
t
ce
ll
w
al
l
de
gr
ad
at
io
n
Y
ES
S1
3
Pc
20
g0
70
30
gi
|2
11
58
79
63
st
ro
ng
si
m
ila
ri
ty
to
1,
4-
be
ta
-Δ
-a
ra
bi
no
xy
la
n
ar
ab
in
of
ur
an
oh
yd
ro
la
se
ax
hA
-
A
sp
er
gi
llu
s
ni
ge
r
N
/A
N
/A
Pl
an
t
ce
ll
w
al
l
de
gr
ad
at
io
n
Y
ES
S1
4
Pc
06
g0
04
30
gi
|2
11
58
12
71
st
ro
ng
si
m
ila
ri
ty
to
ri
bo
nu
cl
ea
se
T2
pr
ec
ur
so
r
rn
tB
-
A
sp
er
gi
llu
s
or
yz
ae
−
2.
7
9.
2E
-0
3
R
ib
on
uc
le
as
e
ac
ti
vi
ty
Y
ES
M.-S. Jami et al. Journal of Proteomics 187 (2018) 243–259
258
[18] J.M. Mingot, M.A. Peñalva, J.M. Fernández-Cañón, Disruption of phacA, an as-
pergillus nidulans gene encoding a novel cytochrome P450 monooxygenase cata-
lyzing phenylacetate 2-hydroxylation, results in penicillin overproduction, J. Biol.
Chem. 274 (1999) 14545–14550 http://www.ncbi.nlm.nih.gov/pubmed/
10329644 , Accessed date: 12 May 2018.
[19] E. Arias-Barrau, E.R. Olivera, J.M. Luengo, C. Fernández, B. Galán, J.L. García,
E. Díaz, B. Miñambres, The homogentisate pathway: a central catabolic pathway
involved in the degradation of L-phenylalanine, L-tyrosine, and 3-hydro-
xyphenylacetate in Pseudomonas putida, J. Bacteriol. 186 (2004) 5062–5077,
https://doi.org/10.1128/JB.186.15.5062-5077.2004.
[20] F. Ferrer-Sevillano, J.M. Fernández-Cañón, Novel phacB-encoded cytochrome P450
monooxygenase from aspergillus nidulans with 3-hydroxyphenylacetate 6-hydro-
xylase and 3,4-dihydroxyphenylacetate 6-hydroxylase activities, Eukaryot. Cell 6
(2007) 514–520, https://doi.org/10.1128/EC.00226-06.
[21] T. Veiga, D. Solis-Escalante, G. Romagnoli, A. ten Pierick, M. Hanemaaijer,
A.T. Deshmukh, A. Deshmuhk, A. Wahl, J.T. Pronk, J.-M. Daran, Resolving phe-
nylalanine metabolism sheds light on natural synthesis of penicillin G in Penicillium
chrysogenum, Eukaryot. Cell 11 (2012) 238–249, https://doi.org/10.1128/EC.
05285-11.
[22] D.M. Harris, Z.A. van der Krogt, P. Klaassen, L.M. Raamsdonk, S. Hage, M.A. van
den Berg, R.A.L. Bovenberg, J.T. Pronk, J.-M. Daran, Exploring and dissecting
genome-wide gene expression responses of Penicillium chrysogenum to phenyla-
cetic acid consumption and penicillinG production, BMC Genomics 10 (2009) 75,
https://doi.org/10.1186/1471-2164-10-75.
[23] M.-S. Jami, C. García-Estrada, C. Barreiro, A.-A. Cuadrado, Z. Salehi-Najafabadi, J.-
F. Martín, The Penicillium chrysogenum extracellular proteome. Conversion from a
food-rotting strain to a versatile cell factory for white biotechnology, Mol. Cell.
Proteomics 9 (2010) 2729–2744, https://doi.org/10.1074/mcp.M110.001412.
[24] J. Casqueiro, O. Bañuelos, S. Gutiérrez, M.J. Hijarrubia, J.F. Martín,
Intrachromosomal recombination between direct repeats in Penicillium chryso-
genum: gene conversion and deletion events, Mol Gen Genet 261 (1999) 994–1000
http://www.ncbi.nlm.nih.gov/pubmed/10485291 , Accessed date: 12 May 2018.
[25] C. García-Estrada, R.V. Ullán, T. Velasco-Conde, R.P. Godio, F. Teijeira, I. Vaca,
R. Feltrer, K. Kosalková, E. Mauriz, J.F. Martín, Post-translational enzyme mod-
iﬁcation by the phosphopantetheinyl transferase is required for lysine and penicillin
biosynthesis but not for roquefortine or fatty acid formation in Penicillium chry-
sogenum, Biochem. J. 415 (2008) 317–324, https://doi.org/10.1042/BJ20080369.
[26] R.V. Ullán, R.P. Godio, F. Teijeira, I. Vaca, C. García-Estrada, R. Feltrer,
K. Kosalkova, J.F. Martín, RNA-silencing in Penicillium chrysogenum and
Acremonium chrysogenum: validation studies using beta-lactam genes expression,
J. Microbiol. Methods 75 (2008) 209–218, https://doi.org/10.1016/j.mimet.2008.
06.001.
[27] J.M. Cantoral, B. Díez, J.L. Barredo, E. Alvarez, J.F. Martín, High–frequency
transformation of Penicillium chrysogenum, Nat. Biotechnol. 5 (1987) 494–497,
https://doi.org/10.1038/nbt0587-494.
[28] F. Fierro, C. García-Estrada, N.I. Castillo, R. Rodríguez, T. Velasco-Conde, J.-
F. Martín, Transcriptional and bioinformatic analysis of the 56.8 kb DNA region
ampliﬁed in tandem repeats containing the penicillin gene cluster in Penicillium
chrysogenum, Fungal Genet. Biol. 43 (2006) 618–629, https://doi.org/10.1016/j.
fgb.2006.03.001.
[29] C. García-Estrada, I. Vaca, M. Lamas-Maceiras, J.F. Martín, In vivo transport of the
intermediates of the penicillin biosynthetic pathway in tailored strains of
Penicillium chrysogenum, Appl. Microbiol. Biotechnol. 76 (2007) 169–182, https://
doi.org/10.1007/s00253-007-0999-4.
[30] G. Candiano, M. Bruschi, L. Musante, L. Santucci, G.M. Ghiggeri, B. Carnemolla,
P. Orecchia, L. Zardi, P.G. Righetti, Blue silver: a very sensitive colloidal Coomassie
G-250 staining for proteome analysis, Electrophoresis 25 (2004) 1327–1333,
https://doi.org/10.1002/elps.200305844.
[31] J. Havlis, H. Thomas, M. Sebela, A. Shevchenko, Fast-response proteomics by ac-
celerated in-gel digestion of proteins, Anal. Chem. 75 (2003) 1300–1306 http://
www.ncbi.nlm.nih.gov/pubmed/12659189 , Accessed date: 12 May 2018.
[32] A.J. Moyer, R.D. Coghill, Penicillin: X. The eﬀect of phenylacetic acid on Penicillin
production, J. Bacteriol. 53 (1947) 329–341 http://www.ncbi.nlm.nih.gov/
pubmed/16561276 , Accessed date: 12 May 2018.
[33] S. Subramani, Protein import into peroxisomes and biogenesis of the organelle,
Annu. Rev. Cell Biol. 9 (1993) 445–478, https://doi.org/10.1146/annurev.cb.09.
110193.002305.
[34] J.-F. Martín, C. García-Estrada, R.V. Ullán, Transport of substrates into peroxisomes:
the paradigm of β-lactam biosynthetic intermediates, Biomol. Concepts 4 (2013)
197–211, https://doi.org/10.1515/bmc-2012-0048.
[35] J.M. Fernández-Cañón, A. Reglero, H. Martínez-Blanco, M.A. Ferrero, J.M. Luengo,
Phenylacetic acid transport system in Penicillium chrysogenum Wis 54–1255:
molecular speciﬁcity of its induction, J. Antibiot. Tokyo 42 (1989) 1410–1415
http://www.ncbi.nlm.nih.gov/pubmed/2507494 , Accessed date: 12 May 2018.
[36] J.M. Fernández-Cañón, A. Reglero, H. Martínez-Blanco, J.M. Luengo, Uptake of
phenylacetic acid by Penicillium chrysogenum Wis 54–1255: a critical regulatory
point in benzylpenicillin biosynthesis, J. Antibiot. Tokyo 42 (1989) 1398–1409
http://www.ncbi.nlm.nih.gov/pubmed/2507493 , Accessed date: 12 May 2018.
[37] D.J. Hillenga, H. Versantvoort, S. van der Molen, A. Driessen, W.N. Konings,
Penicillium chrysogenum takes up the penicillin G precursor Phenylacetic acid by
passive diﬀusion, Appl. Environ. Microbiol. 61 (1995) 2589–2595 http://www.
ncbi.nlm.nih.gov/pubmed/16535072 , Accessed date: 12 May 2018.
[38] M. Fernández-Aguado, R.V. Ullán, F. Teijeira, R. Rodríguez-Castro, J.F. Martín, The
transport of phenylacetic acid across the peroxisomal membrane is mediated by the
PaaT protein in Penicillium chrysogenum, Appl. Microbiol. Biotechnol. 97 (2013)
3073–3084, https://doi.org/10.1007/s00253-012-4425-1.
[39] E. Alvarez, B. Meesschaert, E. Montenegro, S. Gutiérrez, B. Díez, J.L. Barredo,
J.F. Martín, The isopenicillin-N acyltransferase of Penicillium chrysogenum has
isopenicillin-N amidohydrolase, 6-aminopenicillanic acid acyltransferase and pe-
nicillin amidase activities, all of which are encoded by the single penDE gene, Eur.
J. Biochem. 215 (1993) 323–332 http://www.ncbi.nlm.nih.gov/pubmed/8344300
, Accessed date: 12 May 2018.
[40] K. Kosalková, A.T. Marcos, J.F. Martín, A moderate ampliﬁcation of the mecB gene
encoding cystathionine-gamma-lyase stimulates cephalosporin biosynthesis in
Acremonium chrysogenum, J. Ind. Microbiol. Biotechnol. 27 (2001) 252–258,
https://doi.org/10.1038/sj/jim/7000192.
[41] J.F. Martín, A.L. Demain, Unraveling the methionine-cephalosporin puzzle in
Acremonium chrysogenum, Trends Biotechnol. 20 (2002) 502–507 http://www.
ncbi.nlm.nih.gov/pubmed/12443871 , Accessed date: 12 May 2018.
[42] G. Cohen, A. Argaman, R. Schreiber, M. Mislovati, Y. Aharonowitz, The thioredoxin
system of Penicillium chrysogenum and its possible role in penicillin biosynthesis,
J. Bacteriol. 176 (1994) 973–984 http://www.ncbi.nlm.nih.gov/pubmed/8106340
, Accessed date: 12 May 2018.
[43] J. Gerke, O. Bayram, G.H. Braus, Fungal S-adenosylmethionine synthetase and the
control of development and secondary metabolism in Aspergillus nidulans, Fungal
Genet. Biol. 49 (2012) 443–454, https://doi.org/10.1016/j.fgb.2012.04.003.
[44] S. Okamoto, A. Lezhava, T. Hosaka, Y. Okamoto-Hosoya, K. Ochi, Enhanced ex-
pression of S-adenosylmethionine synthetase causes overproduction of actinorhodin
in Streptomyces coelicolor A3(2), J. Bacteriol. 185 (2003) 601–609 http://www.
ncbi.nlm.nih.gov/pubmed/12511507 , Accessed date: 12 May 2018.
[45] X.Q. Zhao, B. Gust, L. Heide, S-Adenosylmethionine (SAM) and antibiotic bio-
synthesis: eﬀect of external addition of SAM and of overexpression of SAM bio-
synthesis genes on novobiocin production in Streptomyces, Arch. Microbiol. 192
(2010) 289–297, https://doi.org/10.1007/s00203-010-0548-x.
[46] P. Shah, J.A. Atwood, R. Orlando, H. El Mubarek, G.K. Podila, M.R. Davis,
Comparative proteomic analysis of Botrytis cinerea Secretome, J. Proteome Res. 8
(2009) 1123–1130, https://doi.org/10.1021/pr8003002.
[47] S. McGoldrick, S.M. O'Sullivan, D. Sheehan, Glutathione transferase-like proteins
encoded in genomes of yeasts and fungi: insights into evolution of a multifunctional
protein superfamily, FEMS Microbiol. Lett. 242 (2005) 1–12, https://doi.org/10.
1016/j.femsle.2004.10.033.
[48] B.P. Girinathan, S.E. Braun, R. Govind, Clostridium diﬃcile glutamate dehy-
drogenase is a secreted enzyme that confers resistance to H2O2, Microbiology 160
(2014) 47–55, https://doi.org/10.1099/mic.0.071365-0.
[49] J. Thykaer, K. Rueksomtawin, H. Noorman, J. Nielsen, NADPH-dependent gluta-
mate dehydrogenase in Penicillium chrysogenum is involved in regulation of beta-
lactam production, Microbiology 154 (2008) 1242–1250, https://doi.org/10.1099/
mic.0.2007/010017-0.
M.-S. Jami et al. Journal of Proteomics 187 (2018) 243–259
259
